Skip to main content
. 2024 Jan 26;12(2):288. doi: 10.3390/biomedicines12020288

Figure 1.

Figure 1

Study design. Flowchart showing the study protocol in HS (VEP recordings) and CM-MOH patients. The time points (T) of VEP recordings are T1 (before rTMS), T2 (immediately after 1 rTMS session), T3 (3 h after the session) in HS and patients, and T4 in patients (after 1 month of twice weekly rTMS-QPI). The time periods for the therapeutic evaluations in CM-MOH patients are C0 (1-month pre-treatment baseline), C1 (during 1 month of twice weekly rTMS-QPI), and C2 (during the post-treatment month).